MARY ISAAC: Open Payments
NPI 1538143961 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 45 payments from 15 companies in 2025. Trend: 2023 $453 · 2024 $625 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $171 |
| PFIZER INC. | 9 | $152 |
| ABBVIE INC. | 5 | $87 |
| GlaxoSmithKline, LLC. | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Madrigal Pharmaceuticals | 1 | $28 |
| IBSA Pharma Inc. | 1 | $18 |
Products named: Rybelsus, Ozempic, CAPLYTA, ELIQUIS, PREVNAR 20, XIFAXAN, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
